Pharmacologic Management of COPD Exacerbations: A Clinical Practice Guideline from the
AAFP | AAFP Advertisement search close brand logo JAMES J. STEVERMER, MD, MSPH …

Exacerbations of chronic obstructive pulmonary disease contribute to the high mortality rate
associated with the disease. Randomized controlled trials have demonstrated the …

Educational aims To describe the impact of COPD exacerbations and the importance of the
frequent exacerbator phenotype. To describe the spectrum of pharmacological and non …

PREVIEW Acute exacerbations of chronic obstructive pulmonary disease (COPD) pose a
continuing threat to quality and length of life in affected patients. As the prevalence of the …

Purpose: The Global Initiative for Chronic Obstructive Lung Disease guidelines provide
recommendations to manage chronic obstructive lung disease (COPD) exacerbations. This …

Exacerbations of chronic obstructive pulmonary disease (COPD) are episodes of worsening
of symptoms, leading to substantial morbidity and mortality. COPD exacerbations are …

For related article see page 1190 guideline in collaboration. A joint ACP-ASIM/ACCP expert
panel examined the evidence and developed recommendations. The guideline and …

A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in
randomised controlled trials on the management of COPD exacerbations | European …

Cochrane for Clinicians Page 1 294 American Family Physician www.aafp.org/afp Volume 99,
Number 5 ◆ March 1, 2019 Cochrane for Clinicians Putting Evidence into Practice Smectite …

Background: COPD exacerbations are an important endpoint in clinical studies. The aim of
the present study is to describe distribution of exacerbations requiring healthcare utilization …